Skip to main content
Tech.euFundingExplorerBeta

Therachon

Develops treatments for serious genetic diseases

Total raised
€32M
€31,818,181
Funding rounds
1
Investors
2
distinct backers
Active since
2015-08
latest 2015-08

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood16
base rate 44% for Series A
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2015-09-01Series A€32MInserm Transfert Initiative,New Enterprise AssociatesView deal →

Similar companies

same sector or country